GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $116,000 | +5.5% | 2,653 | +5.5% | 0.06% | +19.2% |
| Q1 2022 | $110,000 | +175.0% | 2,515 | +176.4% | 0.05% | +173.7% |
| Q4 2021 | $40,000 | -2.4% | 910 | -6.2% | 0.02% | -5.0% |
| Q3 2021 | $41,000 | +5.1% | 970 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $39,000 | +14.7% | 970 | 0.0% | 0.02% | +11.1% |
| Q1 2021 | $34,000 | -5.6% | 970 | 0.0% | 0.02% | -18.2% |
| Q4 2020 | $36,000 | -14.3% | 970 | -14.2% | 0.02% | -21.4% |
| Q3 2020 | $42,000 | -6.7% | 1,130 | 0.0% | 0.03% | -6.7% |
| Q2 2020 | $45,000 | +4.7% | 1,130 | 0.0% | 0.03% | -14.3% |
| Q1 2020 | $43,000 | -46.9% | 1,130 | -34.9% | 0.04% | -34.0% |
| Q4 2019 | $81,000 | +285.7% | 1,735 | +243.6% | 0.05% | +253.3% |
| Q3 2019 | $21,000 | +31.2% | 505 | +26.2% | 0.02% | +36.4% |
| Q2 2019 | $16,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $16,000 | +6.7% | 400 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $15,000 | -6.2% | 400 | 0.0% | 0.01% | +9.1% |
| Q3 2018 | $16,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $16,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $16,000 | -27.3% | 400 | -36.0% | 0.01% | -31.2% |
| Q4 2017 | $22,000 | -18.5% | 625 | -7.4% | 0.02% | -23.8% |
| Q3 2017 | $27,000 | -6.9% | 675 | 0.0% | 0.02% | -8.7% |
| Q2 2017 | $29,000 | +26.1% | 675 | +22.7% | 0.02% | +43.8% |
| Q1 2017 | $23,000 | +21.1% | 550 | +10.0% | 0.02% | +23.1% |
| Q4 2016 | $19,000 | 0.0% | 500 | +11.1% | 0.01% | -7.1% |
| Q3 2016 | $19,000 | +11.8% | 450 | +12.5% | 0.01% | +16.7% |
| Q2 2016 | $17,000 | +6.2% | 400 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $16,000 | -5.9% | 400 | 0.0% | 0.01% | -7.7% |
| Q4 2015 | $17,000 | +13.3% | 400 | 0.0% | 0.01% | +8.3% |
| Q3 2015 | $15,000 | -11.8% | 400 | 0.0% | 0.01% | -7.7% |
| Q2 2015 | $17,000 | -29.2% | 400 | -23.8% | 0.01% | -27.8% |
| Q1 2015 | $24,000 | +41.2% | 525 | +31.2% | 0.02% | +38.5% |
| Q4 2014 | $17,000 | -5.6% | 400 | 0.0% | 0.01% | -7.1% |
| Q3 2014 | $18,000 | -14.3% | 400 | 0.0% | 0.01% | -12.5% |
| Q2 2014 | $21,000 | 0.0% | 400 | 0.0% | 0.02% | -5.9% |
| Q1 2014 | $21,000 | 0.0% | 400 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $21,000 | +5.0% | 400 | 0.0% | 0.02% | -5.6% |
| Q3 2013 | $20,000 | 0.0% | 400 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $20,000 | – | 400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |